Modern Vaccines/Adjuvants Formulation Session 6: Vaccine & Adjuvant Formulation & Production 15-17 May 2013, Lausanne, Switzerland

Por Fox, Christopher B
Publicado em 2013

Adjuvants for Leishmania vaccines: from models to clinical application

Por Raman, Vanitha S., Duthie, Malcolm S., Fox, Christopher B., Matlashewski, Greg, Reed, Steven G.
Publicado em 2012

Immunomodulatory and Physical Effects of Oil Composition in Vaccine Adjuvant Emulsions

Por Fox, Christopher B., Baldwin, Susan L., Duthie, Malcolm S., Reed, Steven G., Vedvick, Thomas S.
Publicado em 2011

Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions

Por Fox, Christopher B., Baldwin, Susan L., Duthie, Malcolm S., Reed, Steven G., Vedvick, Thomas S.
Publicado em 2012

Effects on Immunogenicity by Formulations of Emulsion-Based Adjuvants for Malaria Vaccines

Por Fox, Christopher B., Baldwin, Susan L., Vedvick, Thomas S., Angov, Evelina, Reed, Steven G.
Publicado em 2012

Working together: interactions between vaccine antigens and adjuvants

Por Fox, Christopher B., Kramer, Ryan M., Barnes V, Lucien, Dowling, Quinton M., Vedvick, Thomas S.
Publicado em 2013

Editorial

Por Ambrose, Christopher S., Bhattacharya, Jayanta, Fox, Christopher B., McIntosh, E. David G., Stern, Peter L.
Publicado em 2013

Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica

Por Abhyankar, Mayuresh M., Noor, Zannatun, Tomai, Mark A., Elvecrog, James, Fox, Christopher B., Petri, William A.
Publicado no Vaccine (2017)

In Vitro Evaluation of TLR4 Agonist Activity: Formulation Effects

Por Misquith, Ayesha, Millie Fung, H. W., Dowling, Quinton M., Guderian, Jeffrey A., Vedvick, Thomas S., Fox, Christopher B.
Publicado em 2013

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93

Por Orr, Mark T., Beebe, Elyse A., Hudson, Thomas E., Moon, James J., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Publicado em 2014

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes

Por Fox, Christopher B, Mulligan, Sean K, Sung, Joyce, Dowling, Quinton M, Fung, H W Millie, Vedvick, Thomas S, Coler, Rhea N
Publicado em 2014

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

Por Fung, HW Millie, Mikasa, Traci JT, Vergara, Julie, Sivananthan, Sandra J, Guderian, Jeffrey A, Duthie, Malcolm S, Vedvick, Thomas S, Fox, Christopher B
Publicado em 2013

Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis

Por Jakob, Virginie, Brunner, Livia, Barnier-Quer, Christophe, Blust, Molly, Collin, Nicolas, Carter, Lauren, Carter, Darrick, Rausch, Kelly M., Fox, Christopher B.
Publicado no Ther Adv Vaccines (2017)

Self-Assembly of a Triangle-Shaped, Hexaplatinum-Incorporated, Supramolecular Amphiphile in Solution and at Interfaces

Por Maran, Umamageswaran, Britt, David, Fox, Christopher B., Harris, Joel M., Orendt, Anita M., Conley, Hiram, Davis, Robert, Hlady, Vladamir, Stang, Peter J.
Publicado em 2009

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7

Por Fox, Christopher B, Sivananthan, Sandra J, Duthie, Malcolm S, Vergara, Julie, Guderian, Jeffrey A, Moon, Elliot, Coblentz, David, Reed, Steven G, Carter, Darrick
Publicado em 2014

Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic T(H)1 to tissue-resident T(H)17 responses without impacting the protective efficacy(§)

Por Orr, Mark T., Beebe, Elyse A., Hudson, Thomas, Argilla, David, Huang, Po-Wei D., Reese, Valerie A., Fox, Christopher B., Reed, Steven G., Coler, Rhea N.
Publicado no Vaccine (2015)

IL-18 and subcapsular lymph node macrophages are essential for enhanced B cell responses with TLR4 agonist adjuvants()

Por Desbien, Anthony L., Cauwelaert, Natasha Dubois, Reed, Steven J., Bailor, Hilton R., Liang, Hong, Carter, Darrick, Duthie, Malcolm S., Fox, Christopher B., Reed, Steven G., Orr, Mark T.
Publicado no J Immunol (2016)

Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis

Por Orr, Mark T., Fox, Christopher B., Baldwin, Susan L., Sivananthan, Sandra J., Lucas, Elyse, Lin, Susan, Phan, Tony, Moon, James J., Vedvick, Thomas S., Reed, Steven G., Coler, Rhea N.
Publicado em 2013

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization

Por Orr, Mark T., Kramer, Ryan M., Barnes, Lucien V, Dowling, Quinton M., Desbien, Anthony L., Beebe, Elyse A., Laurance, John D., Fox, Christopher B., Reed, Steven G., Coler, Rhea N., Vedvick, Thomas S.
Publicado em 2013

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant

Por Coler, Rhea N., Bertholet, Sylvie, Moutaftsi, Magdalini, Guderian, Jeff A., Windish, Hillarie Plessner, Baldwin, Susan L., Laughlin, Elsa M., Duthie, Malcolm S., Fox, Christopher B., Carter, Darrick, Friede, Martin, Vedvick, Thomas S., Reed, Steven G.
Publicado em 2011